295349-63-2 Usage
Description
2-(4-Morpholinyl)-pyridine-4-carboxylic acid tert-butyl ester is a chemical compound with the molecular formula C17H24N2O4. It is a derivative of pyridine and contains a morpholine and tert-butyl ester functional group. 2-(4-MORPHOLINYL)-PYRIDINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER is known for its potential applications in the pharmaceutical and organic synthesis industries.
Uses
Used in Pharmaceutical Industry:
2-(4-Morpholinyl)-pyridine-4-carboxylic acid tert-butyl ester is used as an intermediate for the synthesis of various drugs and pharmaceutical products. Its unique structure allows it to be a key component in the development of new medications.
Used in Organic Synthesis:
In the field of organic synthesis, 2-(4-Morpholinyl)-pyridine-4-carboxylic acid tert-butyl ester is utilized for the preparation of novel chemical compounds. Its versatility in chemical reactions makes it a valuable asset for creating new molecules with potential applications in various industries.
Used in Medicinal Chemistry:
Due to its potential biological activities, 2-(4-Morpholinyl)-pyridine-4-carboxylic acid tert-butyl ester may have applications in the field of medicinal chemistry. Researchers can explore its properties to develop new therapeutic agents or improve existing ones.
Check Digit Verification of cas no
The CAS Registry Mumber 295349-63-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,5,3,4 and 9 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 295349-63:
(8*2)+(7*9)+(6*5)+(5*3)+(4*4)+(3*9)+(2*6)+(1*3)=182
182 % 10 = 2
So 295349-63-2 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2O3/c1-14(2,3)19-13(17)11-4-5-15-12(10-11)16-6-8-18-9-7-16/h4-5,10H,6-9H2,1-3H3
295349-63-2Relevant articles and documents
HETEROCYCLIC CYTOKINE INHIBITORS
-
Page/Page column 132-133, (2010/11/27)
The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory, anti-pain or anti-cancer agents. There are further provided m
